Brief: Greenlight Biosciences Announces Fourth Quarter And Full Year 2022 Financial Results
March 28 (Reuters) - Greenlight Biosciences Holdings PBC
GRNA.O :
* GREENLIGHT BIOSCIENCES ANNOUNCES FOURTH QUARTER AND FULL
YEAR
2022 FINANCIAL RESULTS
* GREENLIGHT BIOSCIENCES-EXPECTS CASH,EQUIVALENTS AS OF DEC
31,
2022 TO BE SUFFICIENT TO FUND PLANNED OPERATING EXPENSES AND
CAPEX, THROUGH Q2 OF 2023
Source text for Eikon: ID:nGNX8YDFYj
Further company coverage: GRNA.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Greenlight Biosciences Holdings PBC
See all newsBrief: Greenlight Biosciences To Cut Workforce By About 51%
U.S. RESEARCH ROUNDUP-Microsoft, Chevron, Carisma Therapeutics
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
GreenLight Biosciences gains on deal to be acquired by Fall Line Capital